Welcome Letter
Dear Colleagues,
We are delighted to extend a warm invitation to the 4th RNA Horizons Conference, a distinguished gathering dedicated to advancing the transformative potential of RNA technology in medicine. Building on the success of our previous meetings, where we explored the exciting frontiers of RNA research, we are eager to convene once more.
RNA Horizons 2027 will take place in Prague, Czech Republic from September 21-23, 2027.
This conference will provide a unique platform for:
- Exploring cutting-edge advancements: Delving into the latest research on RNA systems biology, including RNA splicing, editing, and processing.
- Discovering novel therapeutic avenues: Unlocking the potential of RNA therapeutics to modulate cancer, generate immunogenic transcripts, and target cancer vulnerabilities.
- Fostering interdisciplinary collaboration: Connecting with a diverse community of researchers, fostering meaningful partnerships between academia and industry.
We believe that through collaborative effort we can accelerate the translation of groundbreaking RNA research into impactful cancer therapies.
To learn more about the insights and discussions from our previous meetings, please visit www.rnahorizons.com.
We look forward to welcoming you to Prague in September 2027.
RNA Horizons 2027 Organizing Committee
Head of The Hadassah Cancer Research Institute (HCRI)
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Principal Investigator, Perelman School of Medicine
University of Pennsylvania, Philadelphia, USA
Principal Investigator, The Guccione Lab
Icahn School of Medicine at Mount Sinai, New York, NY, USA
